Private Institutions "grab Medicine" Is The Test Of Time Even In The "medication" After
In the private sector, the recent exchanges, the rise of Chinese plate quietly has become a recent hot spot
. Some agents have a high-tech products and features API Production enterprises, as private equity fund managers views on quality of resources.
Slightly in the quality resources have been scarce in the atmosphere, the movement of funds into the medical industry is more rapid, and has a strong purpose.
Necessary investment portfolio, private investment and accelerate the distribution of wind
Speaking of China's current environment, president of The Balloch Group, a founding partner in Balloch, said it was private enterprise in China's best period. He pointed out that "a lot of international businessmen, hoping to China and support China's small and medium enterprises, small and medium private enterprises in China's development is much better than in other countries." Areas for investment, Balloch, said health care, Education And consumption in China has the best investment opportunities.
In building a professional team of pharmaceutical industry and the pharmaceutical industry fund raising success, Kun Jiuding Investment Management Limited (Jiuding investment) followed its efficiency, professionalism, independence consistent style, recently shot repeatedly in the pharmaceutical industry. Following the end of March to the sea through its fund Kellett Pharmaceutical Co., Ltd. Soon after injection of 34,000,000 yuan, early in April, Jiuding investment in the pharmaceutical industry once again shot to the mountain Xipu De Pharmaceutical Limited (Pud medicine) injection 11,000 million, all funds have been credited into account current. Pud medicine and Jiuding invested in more than nine months after a long "love", the last successful "hand."
"Contact us Pud medicine and research, as early as in June 2009 began, followed by ongoing research, negotiation, and even act as a shareholder value-added services in advance the process of much discussion during the experience, ultimately immortal. "Jiuding investment partner Yu Bo told reporters.
"In fact, we not very short of money, investment, however Jiuding deep understanding of the pharmaceutical industry, as well as Pharmaceutical Industry Value-added services provided by the system, making the final successful cooperation. "The mountains Xipu De medicine, said chairman Hu Chengwei so. After the first meeting of both sides, Pud Pharmaceutical Jiuding team left a" job "?? On two pharmaceutical projects and the value of professional advice given. Jiuding investment After a week of professional back, knocking the Pud medicine door to introduce strategic investor, and officially started the process of bilateral cooperation.
U.S. pilot fund investment advisory and managing partner of the Ying Zhao pointed out, private equity frequently shot in the field of medicine, the layout has begun.
Recent investment case, including Chongqing, Germany with 10 million U.S. dollars fund investment in Chongqing Fine Bo Teng Chemical industry Co., Ltd., JP Morgan Chase's private equity investment firm OneEquityPartners shares to 69,600,000 U.S. dollars, Guangzhou Konzern Medicine, Softbank China Venture Capital shares Suzhou Nathon biological nano-technology Co., Ltd., NEA Secretary-resistant carrying BioVeda restructuring health medicine, the risks Four institutional investors invest 7,000,000 U.S. dollars Vian macro first round funding of Anhui Anqing pharmaceutical companies, among others. Medical pharmaceutical industry has become most venture and private equity an integral part of the portfolio.
With the state strategic positioning of the establishment of new industries, venture capital and private equity investment institutions in the field of investment is Small and medium enterprises. And Qing dynasties Research Center on April 11 according to data released in 2009, venture capital and private equity investors in the information industry, new Energy Industry, new materials, pharmaceutical / health care products, bio-engineering, and other strategic investments in new industries the number of cases reached 307, the investment amount of 1.88 billion.
Progress from the perspective of investment in each season, the whole venture capital and private equity investment institutions in strategic areas of the layout of new industries is accelerating, especially in the third quarter of last year's 3 times the development of new industries of strategic forum, the first that occurred in the fourth quarter, 105 new industries of strategic investment, involving an amount of 699 million U.S. dollars, accounting for 34.2% of total annual investment cases and 37.2% of total investment, investment increased by 21 cases over the third quarter, the investment increase of 85.6% .
Private Institutions "grab Medicine" Is The Test Of Time Even In The "medication" After
By: weihua
Drugs In Public Hospitals In Liaoning Province Will Be The Collective Price Cuts Demand For Bulk Drugs Pharmaceutical Enterprise Performance Surge Of Warmer Vital Questions To Ask Before Choosing A Medical Spa Aarkstore Enterprise---ats Medical, Inc. (atsi) - Financial And Strategic Analysis Review Aarkstore Enterprise---inverness Medical Innovations, Inc. (ima) - Financial And Strategic Analysis Medical Billing Software What You Need To Know About Mold Remediation The Maryland Drug Treatment Centers Is There Anything I Can Do When The Prescription Drug Plavix Causes Me To Bruise Easily? Psoriasis Drugs Mold Remediation San Francisco: Freedom From Fungi Medical Hair Restoration Cost Medical Hair Transplant
Private Institutions "grab Medicine" Is The Test Of Time Even In The "medication" After